Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD 20892-1288, USA.
Cytotherapy. 2011 Jul;13(6):661-74. doi: 10.3109/14653249.2010.548379. Epub 2011 Jan 20.
Bone marrow stromal cells (BMSC) are being used for immune modulatory, anti-inflammatory and tissue engineering applications, but the properties responsible for these effects are not completely understood. Human BMSC were characterized to identify factors that might be responsible for their clinical effects and biomarkers for assessing their quality.
Early passage BMSC prepared from marrow aspirates of seven healthy subjects were compared with three human embryonic stem cell (hESC) samples, CD34(+) cells from three healthy subjects and three fibroblast cell lines. The cells were analyzed with oligonucleotide expression microarrays with more than 35 000 probes.
BMSC gene expression signatures of BMSC differed from those of hematopoietic stem cells (HSC), hESC and fibroblasts. Genes upregulated in BMSC were involved with cell movement, cell-to-cell signaling and interaction and proliferation. The upregulated genes most probably belonged to pathways for integrin signaling, integrin-linked kinase (ILK) signaling, NF-E2-related factor-2 (NFR2)-mediated oxidative stress response, regulation of actin-based motility by Rho, actin cytoskeletal signaling, caveolar-mediated endocytosis, clathrin-mediated endocytosis and Wingless-type MMTV integration site (Wnt/β catenin signaling. Among the most highly upregulated genes were structural extracellular matrix (ECM) proteins (α5 and β5 integrin chains, fibronectin and collagen type IIIα1 and Vα1) and functional EMC proteins [connective tissue growth factor (CTGF), transforming growth factor beta-induced protein (TGFBI) and A disintegrin and metalloproteinase (ADAM12)].
Global analysis of human BMSC suggests that they are mobile, metabolically active, proliferative and interactive cells that make use of integrins and integrin signaling. They produce abundant ECM proteins that may contribute to their clinical immune modulatory and anti-inflammatory effects.
骨髓基质细胞(BMSC)正被用于免疫调节、抗炎和组织工程应用,但负责这些作用的特性尚不完全清楚。本研究旨在对人 BMSC 进行特征描述,以确定其临床作用的相关因素和评估其质量的生物标志物。
从 7 名健康供体的骨髓抽吸物中制备早期传代 BMSC,并与 3 个人胚胎干细胞(hESC)样本、3 名健康供体的 CD34+细胞和 3 个人成纤维细胞系进行比较。用包含 35000 多个探针的寡核苷酸表达微阵列对细胞进行分析。
BMSC 的基因表达谱与造血干细胞(HSC)、hESC 和成纤维细胞不同。BMSC 中上调的基因涉及细胞运动、细胞间信号转导和相互作用以及增殖。上调的基因很可能属于整合素信号、整合素连接激酶(ILK)信号、NF-E2 相关因子-2(NFR2)介导的氧化应激反应、Rho 调节肌动蛋白依赖的运动、肌动蛋白细胞骨架信号、小窝介导的内吞作用、网格蛋白介导的内吞作用和 Wingless 型 MMV 整合位点(Wnt/β catenin 信号通路。上调最明显的基因包括结构性细胞外基质(ECM)蛋白(α5 和β5 整合素链、纤连蛋白和胶原蛋白 IIIα1 和 Vα1)和功能性 ECM 蛋白[结缔组织生长因子(CTGF)、转化生长因子β诱导蛋白(TGFBI)和 A 型整合素金属蛋白酶 12(ADAM12)]。
对人 BMSC 的全面分析表明,它们是移动的、代谢活跃的、增殖的和相互作用的细胞,它们利用整合素和整合素信号。它们产生丰富的 ECM 蛋白,这可能有助于其临床免疫调节和抗炎作用。